on Cantourage Group SE (isin : DE000A3DSV01)
Cantourage Secures Market Advantage with LOT420's EU-GMP Certification
Cantourage Group SE has reinforced its market position as Canadian cannabis producer LOT420 receives EU-GMP certification. This move positions LOT420 among the top suppliers in the European medical cannabis sector. The certification promises shorter delivery times, ensuring European pharmacies receive fresher cannabis products.
This development strengthens Cantourage's competitive edge by providing exclusive access to LOT420's products, thereby enhancing its supply chain in the European market. LOT420, already established as a premium supplier, is known for its high-quality craft cannabis produced through refined small-batch cultivation techniques.
The certification aligns with Cantourage's strategy of building a robust network of EU-GMP-certified partners, driving regulatory stability, and operational efficiency. CEO Philip Schetter highlights the importance of high-quality brands, signaling a solid foundation for future growth in the European cannabis market.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news